Hysteroscopic Evaluation and the Clinical Outcomes of Vaginal Repair of Cesarean Section Scar Defects

Launched by XINHUA HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · May 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a condition called cesarean section scar defects (CSDs), which can happen after having a cesarean delivery. These defects may cause issues like spotting between periods. The researchers want to see how well a procedure called hysteroscopy, which allows doctors to look inside the uterus, can help identify these defects and how it relates to the success of a surgical repair done through the vagina. This study is important because there hasn't been much research on using hysteroscopy to evaluate CSDs.

To participate in this trial, women aged between 18 and 45 who are not pregnant and have had one or more cesarean sections may be eligible. They should be experiencing intermenstrual spotting or have specific ultrasound findings related to the defect. However, women with certain health issues, like diabetes or other serious conditions, will not be included. If eligible, participants can expect to undergo imaging tests before the surgery and take part in the hysteroscopy evaluation, helping researchers learn more about this condition and improve treatment options.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • The inclusion criteria are non-pregnant patients who had one or more cesarean sections, patients who had intermenstrual spotting after the cesarean section or those in which the TRM was less than 3.0 mm at the preoperative stage, and patients who underwent MRI and TVS to evaluate the size of the defect and the TRM before surgery
• Exclusion Criteria:
• • Patients who had a history of chronic diseases (such as cerebro-cardiovascular diseases, malignancies and diabetes mellitus), endocrine disorders, menstrual irregularities before cesarean section, coagulation disorders, use of intrauterine devices, sub-mucous myoma, endometrial diseases, endometrial cysts, uterine fibroids, and adenomyosis after cesarean section